MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Medically refractory paroxysmal kinesigenic dyskinesia in a 7 year old with a novel PRRT2 mutation

    K. Chillag, E. Chillag (Wyoming, MI, USA)

    Objective: To describe an atypical case of paroxysmal kinesigenic dyskinesia (PKD) due to a novel PRRT2 mutation.  Background: PRRT2 gene mutations have been reported in a…
  • 2017 International Congress

    Novel TUBB4A variants in idiopathic dystonia

    S. Camargos, C. Dos Santos, F. Silva Junior, E. Barbosa, S.M. Azevedo Silva, V. Borges, J.C. Limongi, M.S. Rocha, H. Ferraz, F. Cardoso, P. Carvalho Aguiar (Belo Horizonte, Brazil)

    Objective: The aim of this study is to investigate TUBB4A variants in patients with idiopathic dystonia. Background: Mutations in TUBB4A, which encodes beta-tubulin 4A, were…
  • 2017 International Congress

    Characterizing task-based acoustic variations of vowels in Parkinson’s disease: Preliminary data

    C. Kuo (Harrisonburg, VA, USA)

    Objective: This is a pilot study that examines changes in the acoustic characteristics of vowels across speaking tasks for individuals with Parkinson’s disease (PD). The…
  • 2017 International Congress

    Helicobacter pylori eradication and risk of Parkinson’s disease in patients with peptic ulcers

    Y.-P. Chang, G.-F. Chiu, Y.-H. Chang, D.-C. Wu (Kaohsiung, Taiwan)

    Objective: To observe the effect of Helicobacter pylori eradication on the incidence of Parkinson's disease Background: The prevalence of Helicobacter pylori (H. pylori) is high in Parkinson's disease (PD)…
  • 2017 International Congress

    Fluvoxamine maleate normalizes striatal neuronal inflammatory cytokine activity in a Parkinsonian rat model associated with depression

    E. Dalle, D. William, M. Musa (Durban, South Africa)

    Objective: The objective of this study was to investigate how fluvoxamine maleate treatment regulates depressive-like symptoms, motor impairments and the expressions of IL-1beta, IL-6, IL-10…
  • 2017 International Congress

    The impact of Parkinson’s disease on faith and spirituality

    A. Weldehana (Addis Ababa, Ethiopia)

    Objective: The objective of the present study is to assess the impact of Parkinson’s disease on faith and spirituality.  Background: There are some controversies on…
  • 2017 International Congress

    Olfaction and gustation in patients with Parkinson’s Disease

    A. Tautscher-Basnett, V. Tomantschger, M. Freimueller (Hermagor, Austria)

    Objective: This study investigates smell and taste function in patients with Parkinson’s Disease (PD). Background: Up to 90% of patients with PD suffer from olfactory…
  • 2017 International Congress

    Neuroanatomical correlates of depressive symptoms in newly diagnosed Parkinson’s disease patients

    S.J. Kim (Busan, Republic of Korea)

    Objective: Depression is the most frequent neuropsychiatric manifestation in Parkinson's disease (PD). Although evidence suggests that depression in PD is related to the degenerative process…
  • 2017 International Congress

    Central Aortic Pressure in Parkinson’s Disease and Levodopa Effect

    M. BALAL, M. DEMIRKIRAN (Adana, Turkey)

    Objective: Central aortic pressure (CAP) is the systolic blood pressure at the root of the aorta. In young people CAP is lower than the peripheral…
  • 2017 International Congress

    Pain and Parkinson’s disease

    H. Wilson, T. Yousaf, G. Pagano, M. Politis (London, United Kingdom)

    Objective: We aimed to explore clinical correlates and risk factors in the development of pain, alongside the relationship between pain and striatal dopaminergic dysfunction in…
  • « Previous Page
  • 1
  • …
  • 31
  • 32
  • 33
  • 34
  • 35
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley